(7-Azabenzotriazol-1-yloxy)tripyrrolidinophosphonium hexafluorophosphate

• Catalog No.: 535303
• CAS Number: 156311-83-0
• M. F.: C17H27F6N7OP2
• M. W.: 521.3805212
• Purity: 96%

SYNONYMS

• Title: 六氟磷酸(7-氮杂苯并三唑-1-氧基)三吡咯烷磷
• IUPAC name: hexafluoro-λ^5-phosphanuide; tris(pyrrolidin-1-yl)({3H-[1,2,3]triazolo[4,5-b]pyridin-3-yloxy})phosphanium
• IUPAC Traditional name: tris(pyrrolidin-1-yl)({[1,2,3]triazolo[4,5-b]pyridin-3-yloxy})phosphanium hexafluorophosphate
• Synonyms: PyAOP; (3-Hydroxy-3H-1,2,3-triazolo[4,5-b]pyridinato-O)tri-1-pyrrolidinyl-phosphorus hexafluorophosphate

DATABASE IDS

• MDL Number: MFCD03703417
• CAS Number: 156311-83-0

PROPERTIES

• Empirical Formula (Hill Notation): C17H27F6N7OP2
• Purity: 96%
• Melting Point: 163-168 °C(lit.)
• GHS Signal Word: Warning
• GHS Hazard statements: H315-H319-H335
• European Hazard Symbols: Irritant (Xi)
• Personal Protective Equipment: dust mask type N95 (US), Eyeshields, Gloves
• GHS Precautionary statements: P261-P305 + P351 + P338
• Risk Statements: 36/37/38
• Safety Statements: 26-36
• Storage Temperature: -20°C
• German water hazard class: 3

DETAILS

Description (English)

Packaging
1, 5 g in poly bottle
Legal Information
Sold under agreement with PE Biosystems
ReactIR is a trademark of Mettler-Toledo, Inc.
Application
Reagent for synthesis of: Cyclic RGC pentapeptides for functionalization through click chemistry1 Fluorescent glucose bioprobes2 ReactIR™ flow cell3Reagent for: Disulfide bond engineering4 Heteroaryl ether synthesis5 Optimization of conformational constraint on non-phosphorylated cyclic peptide antagonists of the Grb2-SH2 domain6

Description (简体中文)

包装
1, 5 g in poly bottle
Legal Information
经 PE Biosystems 授权销售
法律信息
ReactIR is a trademark of Mettler-Toledo, Inc.
Application
Reagent for synthesis of: Cyclic RGC pentapeptides for functionalization through click chemistry1 Fluorescent glucose bioprobes2 ReactIR™ flow cell3Reagent for: Disulfide bond engineering4 Heteroaryl ether synthesis5 Optimization of conformational constraint on non-phosphorylated cyclic peptide antagonists of the Grb2-SH2 domain6